Two new ACIP picks were paid experts against Merck in courtnews2025-06-12T16:19:00+00:00June 12th, 2025|Endpoints News|
Insmed aims to raise $750M in one of the largest stock offerings this yearnews2025-06-12T15:24:55+00:00June 12th, 2025|Endpoints News|
#EHA25: Kura, Kyowa say Phase 1 update supports menin inhibitor combos news2025-06-12T15:19:00+00:00June 12th, 2025|Endpoints News|
#EHA25: Schrödinger reports early Phase 1 data for MALT1 inhibitornews2025-06-12T11:00:10+00:00June 12th, 2025|Endpoints News|
Organoid startup raises $21M to test drugs and vaccines in human lymph nodes-in-a-dishnews2025-06-11T19:38:11+00:00June 11th, 2025|Endpoints News|
House appropriators call for FDA tweaks on accelerated approvals, biosimilarsnews2025-06-11T18:21:39+00:00June 11th, 2025|Endpoints News|
Endpoints Livestream: What happens when AI thinks in ways we can’t understand?news2025-06-11T15:32:23+00:00June 11th, 2025|Endpoints News|
Cabaletta Bio shares CAR-T results in three autoimmune conditionsnews2025-06-11T15:29:34+00:00June 11th, 2025|Endpoints News|
Vaxart shares rise after reporting norovirus vaccine datanews2025-06-11T14:12:17+00:00June 11th, 2025|Endpoints News|
BMS’ RayzeBio bags rights for Philochem’s radiopharma asset for $350M upfrontnews2025-06-11T10:39:03+00:00June 11th, 2025|Endpoints News|
